We are live on
!
Find out more
Achieve Life Sciences
ACHV
ACHV
81 hedge funds and large institutions have $63.6M invested in Achieve Life Sciences in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,628% more call options, than puts
Call options by funds: $2.5M | Put options by funds: $145K
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
5% more funds holding
Funds holding: 77 → 81 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.22% less ownership
Funds ownership: 43.66% → 40.43% (-3.2%)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
45% less capital invested
Capital invested by funds: $115M → $63.6M (-$51.7M)
Holders
81
Holders Change
+4
Holders Change %
+5.19%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
17
Increased
17
Reduced
23
Closed
11
Calls
$2.5M
Puts
$145K
Net Calls
+$2.36M
Net Calls Change
+$1.19M
Top Buyers
Top Sellers
| 1 |
Pathstone Holdings
Englewood,
New Jersey
|
-$1.86M |
| 2 |
Goldman Sachs
New York
|
-$1.32M |
| 3 |
Millennium Management
New York
|
-$1.25M |
| 4 |
Jane Street
New York
|
-$913K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$745K |
